革新的がん研究支援室

AMED news

AMED news - Detail

2019.01.25
Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers
A press release from the Japan Agency for Medical Research and Development (AMED):

Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers

  Visit AMED website